A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
Clinical trial NCT01332552 · TERMINATED
Trial details
- NCT number
- NCT01332552
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-14
- Primary completion
- 2011-04-06
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.